Literature DB >> 8133349

Relationship between symptoms and health-related quality of life in chronic lung disease.

J L Viramontes1, B O'Brien.   

Abstract

The authors studied the relationship between patient self-reported symptoms and responses to a general measure of health-related quality of life [Short Form 36 (SF-36)] for 102 patients who had chronic lung disease [forced expiratory volume in one second (FEV1) < 70%]. The primary diagnoses were chronic bronchitis, emphysema, and asthma; the mean age was 62 years, and 46% were women. Based upon Medical Research Council (MRC) symptom scores, the patients' disease severity was classified as mild (21%), moderate (22%), or severe (57%). The SF-36 scores differed significantly between disease severity groups in domains of health perception, physical functioning, physical role, and energy. The SF-36 physical functioning and Oxygen Cost Diagram scores correlated well (r = 0.78). The authors conclude that SF-36 is a useful and valid measure of general health status in patients with chronic lung disorders.

Entities:  

Mesh:

Year:  1994        PMID: 8133349     DOI: 10.1007/bf02599142

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  10 in total

Review 1.  Measuring quality of life in clinical trials: a taxonomy and review.

Authors:  G H Guyatt; S J Veldhuyzen Van Zanten; D H Feeny; D L Patrick
Journal:  CMAJ       Date:  1989-06-15       Impact factor: 8.262

2.  Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease.

Authors:  D A Mahler; K Faryniarz; D Tomlinson; G L Colice; A G Robins; E M Olmstead; G T O'Connor
Journal:  Chest       Date:  1992-08       Impact factor: 9.410

3.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

4.  Quality of life assessment in clinical trials: methodologic issues.

Authors:  N K Aaronson
Journal:  Control Clin Trials       Date:  1989-12

5.  Measurement of general health status of non-oxygen-dependent chronic obstructive pulmonary disease patients.

Authors:  J Alonso; J M Antó; M González; J A Fiz; J Izquierdo; J Morera
Journal:  Med Care       Date:  1992-05       Impact factor: 2.983

6.  A historical and epidemiologic perspective on respiratory symptoms questionnaires.

Authors:  J M Samet
Journal:  Am J Epidemiol       Date:  1978-12       Impact factor: 4.897

7.  A measure of quality of life for clinical trials in chronic lung disease.

Authors:  G H Guyatt; L B Berman; M Townsend; S O Pugsley; L W Chambers
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

8.  Validating the SF-36 health survey questionnaire: new outcome measure for primary care.

Authors:  J E Brazier; R Harper; N M Jones; A O'Cathain; K J Thomas; T Usherwood; L Westlake
Journal:  BMJ       Date:  1992-07-18

9.  Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease.

Authors:  C R McGavin; M Artvinli; H Naoe; G J McHardy
Journal:  Br Med J       Date:  1978-07-22

10.  Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study.

Authors:  A L Stewart; S Greenfield; R D Hays; K Wells; W H Rogers; S D Berry; E A McGlynn; J E Ware
Journal:  JAMA       Date:  1989-08-18       Impact factor: 56.272

  10 in total
  15 in total

1.  Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease.

Authors:  K Stavem
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

2.  Health ratings in relation to illnesses, physical functioning, general mental health and well-being: self-reports of college alumnae, ages <40-80 and older.

Authors:  Grace Wyshak
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

3.  The responsiveness of disease-specific and generic health measures to changes in the severity of asthma among adults.

Authors:  J E Ware; J P Kemp; D A Buchner; A E Singer; K B Nolop; T F Goss
Journal:  Qual Life Res       Date:  1998-04       Impact factor: 4.147

4.  The usefulness of the Functional Status Questionnaire and Medical Outcomes Study Short Form in Parkinson's disease research.

Authors:  L M Rubenstein; M D Voelker; E A Chrischilles; D C Glenn; R B Wallace; R L Rodnitzky
Journal:  Qual Life Res       Date:  1998-05       Impact factor: 4.147

5.  Health-related quality of life and healthcare resource utilization by COPD patients: a comparison of three instruments.

Authors:  R Desikan; H L Mason; M T Rupp; M Skehan
Journal:  Qual Life Res       Date:  2002-12       Impact factor: 4.147

6.  The MOS SF-36 health survey questionnaire in severe chronic airflow limitation: comparison with the Nottingham Health Profile.

Authors:  A J Crockett; J M Cranston; J R Moss; J H Alpers
Journal:  Qual Life Res       Date:  1996-06       Impact factor: 4.147

7.  Assessing patient outcomes in acute exacerbations of chronic bronchitis: the measure your medical outcome profile (MYMOP), medical outcomes study 6-item general health survey (MOS-6A) and EuroQol (EQ-5D).

Authors:  C Paterson; C E Langan; G A McKaig; P M Anderson; G D Maclaine; L B Rose; S J Walker; M J Campbell
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

8.  Quality of life in tuberculosis: patient and provider perspectives.

Authors:  Nadia N Hansel; Albert W Wu; Betty Chang; Gregory B Diette
Journal:  Qual Life Res       Date:  2004-04       Impact factor: 4.147

9.  The utility of estimating population-level trajectories of terminal wellbeing decline within a growth mixture modelling framework.

Authors:  R A Burns; J Byles; D J Magliano; P Mitchell; K J Anstey
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-08-10       Impact factor: 4.328

10.  Quality of life in smokers: focus on functional limitations rather than on lung function?

Authors:  Roeland Mm Geijer; Alfred Pe Sachs; Theo Jm Verheij; Huib Am Kerstjens; Marijke M Kuyvenhoven; Arno W Hoes
Journal:  Br J Gen Pract       Date:  2007-06       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.